Document is current
Any future updates will be listed below
-
Authors
Zhao, Peng
Xu, Yuanzhong
Jiang, Lu-Lin
Fan, Xuejun
Ku, Zhiqiang
Li, Leike
Liu, Xiaoye
Deng, Mi
Arase, Hisashi
Zhu, Jay-Jiguang
Huang, Timothy Y.
Zhao, Yingjun
Zhang, Chengcheng
Xu, Huaxi
Tong, Qingchun
Zhang, Ningyan
An, Zhiqiang https://orcid.org/0000-0001-9309-2335
-
Funding
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP150551 and RP190561)
Welch Foundation (AU-0042-20030616)
- License Information
-
More Information
Article History
Received: 18 August 2021
Accepted: 8 June 2022
First Online: 18 June 2022
Declarations
:
: The University of Texas System has filed a patent application on the LILRB2 targeting antibodies and PZ, NZ, and ZA are named inventors of the patent application.
